Aquaporin-4 (AQP4) is the predominant water channel in mammalian CNS where it is localized at the perivascular astrocytic foot processes abutting brain microvessels. Several lines of evidence suggest that AQP4 is involved in important homeostatic functions and that Specifically, judged by electron microscopic immunogold analysis, the perivascular density of AQP4 in SN exceeds by 70% the perivascular density of AQP4 in the neocortex. An even larger difference in AQP4 labeling was found for astrocytic processes in the neuropil.
INTRODUCTION
Parkinson's disease (PD) is the second most common neurodegenerative disorder in the Western hemisphere, characterized by progressive neuronal cell death predominantly of the dopaminergic neurons (DA) in substantia nigra pars compacta (SNpc) (Hirsch et al. 2013 ).
More than 90% of all cases with PD have unknown etiology and the mechanisms underlying the selective loss of nigral DA neurons are not understood. Evidence is accumulating to suggest that astrocytes might play a role in the pathophysiology of PD (Mena and García De Yébenes 2008) and recent studies in animal models of PD have indicated an involvement of the astrocytic water channel aquaporin-4 (AQP4) (Fan et al. 2008; Sun et al. 2016; Yang et al. 2011; Zhang et al. 2016) . Moreover, MRI studies of patients with PD have revealed an abnormal water accumulation in the SN (Ofori et al. 2015a ). However, the cellular and subcellular expression of AQP4 in the SN is unknown, as is the expression level of AQP4 in the parkinsonian brain.
Studies of other brain regions have revealed that AQP4 is concentrated in astrocytic endfeet
that encompass the blood-brain and brain-liquid interfaces (Nielsen et al. 1997 ) (AmiryMoghaddam and Ottersen 2003; Rash et al. 1998) . The polarized expression of AQP4 in astrocytes is crucial for homeostatic processes maintaining normal function, including water and potassium homeostasis (Nagelhus et al. 1999) . Further, polarized expression of AQP4 has been shown to be important for cell migration (Saadoun et al. 2005 ) and possibly astrocytic Ca 2+ signaling (Thrane et al. 2011) . Loss of the polarized expression of AQP4 has been shown in several pathological conditions, such as stroke (De Castro Ribeiro et al. 2006; Frydenlund et al. 2006) , temporal lobe epilepsy (Alvestad et al. 2013 ) and Alzheimer's disease (Yang et al. 2011 ). Here we used immune-microscopy in healthy mice and mice treated with the parkinsonogenic toxin MPTP to ask whether the SN differs from other brain regions with respect to the expression of AQP4 and whether the expression of AQP4 in SN is sensitive to MPTP.
Our data indicate that astrocytes in the SN differ from those in neocortex by showing a higher level of AQP4, particularly in those endfoot membrane domains that mediate water exchange between brain and blood. Nine days after treatment with MPTP the AQP4 pool in these membrane domains has increased further, and more so than the AQP4 pools in other domains of the astrocyte membrane. AQP4 overexpression in specific astrocyte membrane domains may contribute to the water dyshomeostasis observed in patients with PD.
EXPERIMENTAL PROCEDURES Animals
Male wild type C57BL/6 mice 8-12 weeks were used in this study. Experimental protocols were approved by the Institutional Animal Care and Use Committee and conform to National
Institutes of Health guidelines for the care and use of animals.
Tissue preparation

Untreated animals
Animals were anesthetized deeply with hypnorm dormicum (0.105 mg/kg) followed by intracardial perfusion. For light microscopy of untreated SN and neocortex, the animals (n=5)
were perfusion-fixed with 4% formaldehyde (FA) in 0.1M phosphate buffer (PB) (SigmaAldrich, St. Louis, MO, USA) using pH-shift (Eilert-Olsen et al. 2012 ) starting with pH 6.0 for 5 minutes, then shifting to pH 10.5 for 10 minutes. The brains were dissected out and postfixed overnight in 4% FA with pH 10.5. Animals used for electron microscopy (n=3) were perfusion-fixed with 4% FA and 0.1% glutaraldehyde (GA) in 0.1 PB (Sigma-Aldrich), and then post-fixed in the same solution overnight. All brains were stored in a 1:10 dilution of their respective fixative at 4 • C until further preparations.
MPTP and saline treated animals
Mice were treated with either MPTP or saline, following an acute protocol as previously described (Puchades et al. 2013; Jackson-Lewis et al. 1995; Vernice and Serge 2007 Jackson-Lewis et al. 1995) . Nine days after the last injection, both groups of animals were deeply anesthetized with pentobarbital (0.1mL/50g body weight) followed by transcardial perfusion of either 4% FA and 0.1% GA or 4% FA for 10 min and post-fixed in situ overnight (Puchades et al. 2013) . Tissue samples from the 4% FA fixed brains were used for immunofluorescence analysis and samples from both fixatives were used for the immunogold analysis. The difference in the fixatives did not have any impact on the density of the immunogold labeling (data not shown). The brains were dissected out and either processed for electron microscopy or cut into 30 µm coronal sections using a Vibratome (Microm, Jacksonville, FL, USA) for immunohistochemistry and stored at 4ºC in 1/10 fixative until further preparations.
Immunofluorescence and confocal microscopy
The immunofluorescence labeling was performed as described previously (Yang et al. 2011 ).
In brief, the sections were treated with 10% normal goat serum (NGS) and 1% bovine serum albumin (BSA) upon incubation with primary antibodies overnight in 3% NGS, 1% BSA, 0.5%
Triton-X-100 and 0.05% sodium azide in 0.01M phosphate buffer saline (all chemicals from Sigma-Aldrich). Following washing, the sections were incubated with secondary antibodies, washed in PBS, and mounted with Prolong Gold Antifade Reagent with DAPI (Invitrogen, Norway). A complete list of the primary and secondary antibodies used in this study is presented in Table 1 . Images were collected with a LSM 510 META Confocal Microscope (Zeiss, Jena, Germany) using a 40x oil objective. DAPI fluorescence was captured at 405 nm, Alexa 488 at 510 nm, Cy3 at 568 nm and Cy5 at 670 nm. Tissue blocks of 1x1 mm from SNpc and parietal cortex were dissected out using a dissection microscope (Olympus SZX12, Tokyo, Japan). The tissue blocks were subjected to freeze substitution procedure as previously described (van Lookeren Campagne et al. 1991) for the untreated animals and for the MPTP and saline treated animals. In brief, the tissue blocks were cryo-protected in glycerol and rapidly frozen in liquid propane at -170ºC. The frozen tissue was immersed into anhydrous methanol containing 1.5% uranyl acetate at 90ºC in an automatic freeze substitution unit (EMAFS, Leica, Vienna, Austria), infiltrated with Lowicryl HM20 Resin (Lowy, Waldkraiburg, Germany) at -30ºC and polymerized by ultraviolet light.
Ultrathin sectioning and immunogold labeling were performed as described previously (Hoddevik et al. 2016) . Briefly, the blocks were cut into ultrathin sections of 90-100 nm using an ultramicrotome (Leica EM UC6, Vienna, Austria), transferred to mesh grids and incubated in drops of Tris-buffered saline (HCl 0.3%, NaCl 0.01%) with 0.1% triton (TBST) and 50 mM glycine for 10 minutes, washed in double distilled water and then incubated for 10 minutes in TBST containing 2% w/v human serum albumin (HSA). The grids were then incubated in a solution of 2% w/v HSA in TBST and the primary antibody (table 1) 
Quantification and statistical analysis
Postembedding immunogold microscopy and quantification of AQP4 labeling 
RESULTS
AQP4 in normal, untreated animals
Immunofluorescence analysis demonstrated highly polarized expression of AQP4 around blood vessels in SNpc (Fig. 1A-D) and neocortex ( Fig. 1E-H) . In neocortex, AQP4 is scarce in the neuropil and around profiles positive for the neuronal marker TuJ1 (Fig. 1E-H ).
In the SNpc, AQP4 is abundantly expressed with a particularly pronounced labeling in perivascular astrocyte processes. AQP4 immunolabeling is also found in non-endfoot membranes in the neuropil. A similar pattern occurs in the pars reticulata, where the density of TH positive cells is lower and the density of GFAP positive cells is higher than in the pars compacta ( Fig. 1A-D ).
In line with the immunofluorescence labeling, electron micrograph images demonstrated a particularly dense immunolabeling of AQP4 in the SN ( Fig. 2A ) compared to neocortex (Fig.   2B ). AQP4 immunogold particles were concentrated in perivascular endfoot membranes, and were also numerous in fine astrocytic processes in the neuropil. Compared to the neocortex, the SN showed stronger AQP4 immunolabeling both perivascularly (Fig. 2C ) and in neuropil (Fig. 2D) . In the SN, perivascular labeling was 70% higher than in the neocortex, with a mean linear density of 28.4 ± 1.0 gold particles/µm compared to 16.8 ± 0.7 gold particles/µm in the neocortex (p<0.001). Non-endfoot labeling was measured as areal density of gold particles in randomly selected images from neuropil. In the SN, density of AQP4 immunogold particles was 12.7 ± 1.6 gold particles/µm 2 , compared to 5.5 ± 0.5 gold particles/µm 2 in the neocortex (p<0.001) (values are mean ± SEM). These results complement and extend the immunofluorescence data.
AQP4 in MPTP-treated animals
MPTP induces dopaminergic cell death, as seen by loss of tyrosine hydroxylase (TH) positive cells. The method of quantification and the level of degeneration of TH positive neurons in the SNpc in the MPTP treated mice were previously described (Puchades et al. 2013) . MPTP treatment led to a 42% reduction in the density of TH positive cell bodies (Puchades et al. 2013 ). Immunofluorescence analysis of SN revealed that MPTP injections led to strong upregulation of AQP4, both perivascularly and in non-endfoot membranes (Fig. 3A, B) .
Upregulation of glial fibrillary acidic protein (GFAP) was also observed, indicating reactive astrogliosis ( Fig. 3C-D) . This is consistent with previous findings (Puchades et al. 2013) . No change was found in control animals injected with saline ( Fig. 3E-H ).
In accordance with the immunofluorescence labeling, immunoelectron microscopy of SNpc of MPTP treated animals showed an increased expression of AQP4 both in the perivascular endfoot membranes and in the non-endfoot membranes in the neuropil (Fig. 4) .
The quantitative analysis of MPTP treated animals revealed in SNpc a significantly higher expression of AQP4 in the adluminal as well as the abluminal membranes of perivascular endfeet. The adluminal labeling was 30% higher in MPTP treated animals than in saline controls, with a mean linear density of 30.3 ± 1.21 gold particles/µm and 23.5 ± 1.05 (p< 0.05), respectively (Fig. 5A ). The abluminal labeling was 34% higher in the MPTP treated animals than in the saline controls with a mean linear density of 15.3 ± 1.02 gold particles/ µm compared to 11.4 ± 0.71 in the saline controls (p < 0.01) (Fig. 5A ). In line with the immunofluorescence data, the quantitative immunogold analysis revealed an increased expression of AQP4 in the non-endfoot astrocytic membranes following MPTP injections.
The neuropil labeling was 21% higher in the animals treated with MPTP, with a mean linear density of 6.3 ± 0.36 gold particles / µm 2 compared to 5.2 ± 0.28 (p = 0.019) (Fig. 5B) .
Administration of MPTP also caused a modest increase in perivascular AQP4
immunolabeling in the neocortex. The changes were restricted to the adluminal membrane domains (Fig. 5C ).
Information is scant on the microscopic and fine structural localization of AQP4 in the SN.
This void must be filled, as aquaporins and water homeostasis have become increasingly relevant in the context of PD. Notably, experimental data suggest that the toxin susceptibility of dopaminergic neurons depends on the level of AQP4 expression (Zhang et al. 2016 ) and a recent report based on a diffusion MRI technique has shown increased levels of free water in SNpc of patients with PD (Ofori et al. 2015b ). There was a positive correlation between
Montreal Cognitive Assessment scores and free water values in SNpc (Ofori et al. 2015a; Ofori et al. 2015b ).
Our study is the first detailed study of AQP4 in the SN and shows that the perivascular AQP4 pool -which is relatively large even in normal animals -is further increased after treatment with MPTP. This suggests an involvement of AQP4 in PD and may explain why PD patients exhibit water accumulation in SN. These data contrast with findings in Alzheimer's disease, stroke and epilepsy, in which the perivascular AQP4 pool is reduced (Yang et al. 2011; Frydenlund et al. 2006; Alvestad et al. 2013) . After experimental stroke, the endfoot pool of AQP4 is unaltered or increased in the initial phase, but then decreases sharply to very low levels at ~24 h of the ischemic episode (Frydenlund et al. 2006 ; De Castro Ribeiro et al.
2006)
Our results show that AQP4 is more plentiful in the SN than in the neocortex, both in endfoot membranes encompassing microvessels and in non-endfoot astrocytic membranes in the neuropil. This high density of AQP4 was further increased following injections of MPTP. Our conclusions were based on a postembedding immunogold technique that has been modified so as to enable a precise localization and quantification of membrane-bound AQP4 (AmiryMoghaddam and Ottersen 2013; Takumi et al. 1998 ).
Attempts to identify mechanisms underlying the selective vulnerability of dopaminergic cells in the SNpc have focused primarily on the neurons. Although astrocytes are known to be essential in maintenance of homeostatic processes and neuronal function, little is known about their roles in the pathophysiology of PD. The density of astrocytes in the SNpc is low compared to that in other regions (Ji et al. 2008 ). As astrocytes release a variety of growth factors under normal conditions (Swanson et al. 2002) , one could ask if this low density of astrocytes in SNpc would contribute to the susceptibility of local dopaminergic neurons.
Another question is whether nigral astrocytes differ from other astrocytes when it comes to DISCUSSION their roles in maintaining key homeostatic functions. The present analysis of AQP4 was prompted by this question.
To shed light on the potential role of astrocytes and AQP4 in the pathophysiology of PD, we studied AQP4 expression pattern in an acute MPTP mouse model of PD. MPTP induces a parkinsonian syndrome by inactivating complex I of the electron transfer chain (Nicklas et al. 1987 ). It has also been reported that MPTP treatment leads to astrogliosis in SNpc, as well as in striatum (Puchades et al. 2013) . In this respect, it should be noted that the death of dopamine neurons increases between day 1 and 4 after MPTP treatment, and the number of degenerated neurons is thereafter stable for at least one month (Jackson-Lewis et al. 1995) .
Astrogliosis follows a similar time course; starting at day1 and increasing till day 7 after MPTP, when it reaches a plateau where the number of reactive astrocytes is more or less stable for one month (Hou et al. 2017) .
Our study revealed a general upregulation of AQP4 expression in SNpc in the animals treated with MPTP. The high resolution immunogold analysis allowed us to distinguish between different subcellular AQP4 pools and identified a pronounced increase in the density of AQP4
in the astrocytic endfoot membranes that enwrap capillaries and microvessels. This perivascular pool of AQP4 is the one that is directly engaged in water exchange between blood and brain and that controls the influx of water in pathological conditions such as stroke and hyponatremic brain edema Amiry-Moghaddam et al. 2004 ). An increased perivascular pool of AQP4 would make the SN more prone to water accumulation -thus providing a possible mechanistic explanation for the abnormal water contents seen in SN of patients with PD (Ofori et al. 2015a ).
The present data call for further studies to disentangle the possible coupling between astrocytic dysfunction and the propensity for developing PD -be it in its idiopathic form or in response to known parkinsonogenic drugs. A number of neurological conditions have been associated with perturbations of water and ion homeostasis, and mislocalization of astrocytic AQP4 occurs in human temporal lobe epilepsy as well as in animal models of stroke and
Alzheimer's disease (Eid et al. 2005; Yang et al. 2011) . In the kainate model of epilepsy, mislocalization of AQP4 was found to precede the development of overt seizures, suggesting a role in pathogenesis (Alvestad et al. 2013) . In terms of AQP4 mislocalization, PD differs from the above conditions in showing an increase, rather than a decrease, of AQP4 in perivascular membranes.
It should be emphasized that the increase in the expression of AQP4 which is observed in our study can not be explained solely by gliosis. Indeed, gliosis is observed in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy and in the mouse models of Alzheimer's disease. In both conditions gliosis is associated with a loss rather than an increase of endfoot AQP4 (Eid et al. 2005; Yang et al. 2011) . Also in a model of cerebral malaria there is an overall decrease in AQP4 expression, despite extensive gliosis (Promeneur et al. 2013) . Further studies are needed to unravel the mechanistic link between AQP4 expression and proneness to PD and -in a longer time perspective -to ascertain whether astrocytes could serve as targets of new therapies. No significant alteration in the AQP4 expression was detected in the astrocytic abluminal membrane domains (C).
